Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig.

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution Linda W. Martin, MD, Arlene.

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Complete Metabolic Response Is Not Uniformly Predictive of Complete Pathologic Response After Induction Therapy for Esophageal Cancer Brendon M. Stiles,

Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer Stephen G. Swisher, MD, Mary Maish, MD, Jeremy J. Erasmus, MD, Arlene.

Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Puja Gaur, MD, Wayne L. Hofstetter, MD, B

Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population Edmund S. Kassis, MD, Ara A. Vaporciyan,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly Trevor Williams,

Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Tina Cascone, MD, PhD, Kathryn A. Gold, MD, Stephen G

Non-Small Cell Lung Cancer Resection in Lymphoma Patients

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Emanuela Taioli, MD, PhD, Andrea S

David C. Rice, MB, BCh, Matthew A

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Anthony J. Ascioti, MD, Wayne L. Hofstetter, MD, Michael J

Shanda H. Blackmon, MD, Arlene M

Dylan R. Nieman, MD, PhD, Christian G. Peyre, MD, Thomas J

Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System Wayne Hofstetter, MD, Arlene M. Correa, PhD, Neby Bekele, PhD, Jaffer A.

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy Arya Amini, BA, Arlene.

Dhakshina Moorthy Ganeshan, MD, Arlene M

Use of Amiodarone After Major Lung Resection

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Primary Cardiac Sarcoma

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients Raja.

Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Characteristics of Malignant Pleural Mesothelioma in Women

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Management of Primary Pulmonary Artery Sarcomas

Joseph S. Friedberg, MD, Melissa J

David C. Rice, MB, BCh, Jeremy J. Erasmus, MD, Craig W

Zaid M. Abdelsattar, MD, MS, K

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma Marc de Perrot, MD, Karen McRae, MD, Masaki.

Mara B. Antonoff, MD, Wayne L. Hofstetter, MD, Arlene M

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma Valerie W. Rusch, MDa, Kenneth.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Luis F. Tapias, MD, Douglas J. Mathisen, MD, Cameron D

Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung Yung-Han Sun, MS, Shih-Wei Lin, PhD, Chih-Cheng Hsieh, MD,

Kirk A. Caddell, MS, Christopher B. Komanapalli, MD, Matthew S

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

The Risk and Outcomes of Reoperative Tricuspid Valve Surgery

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Predictors of Pleural Implants in Patients With Thymic Tumors

Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter Joe B Putnam, MD, Garrett L Walsh, MD, Stephen G Swisher,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer Stephen G. Swisher, MD, Wayne Hofstetter, MD, Ritsuko Komaki, MD, Arlene.

Jenifer L. Marks, MD, Wayne Hofstetter, MD, Arlene M

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.

Presentation transcript:

Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma David C. Rice, MB, BCh, Craig W. Stevens, MD, PhD, Arlene M. Correa, PhD, Ara A. Vaporciyan, MD, Anne Tsao, MD, Kenneth M. Forster, PhD, Garrett L. Walsh, MD, Stephen G. Swisher, MD, Wayne L. Hofstetter, MD, Reza J. Mehran, MD, MS, Jack A. Roth, MD, Zhongxing Liao, MD, W. Roy Smythe, MD The Annals of Thoracic Surgery Volume 84, Issue 5, Pages 1685-1693 (November 2007) DOI: 10.1016/j.athoracsur.2007.04.076 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival for the entire cohort, n = 100. The Annals of Thoracic Surgery 2007 84, 1685-1693DOI: (10.1016/j.athoracsur.2007.04.076) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival stratified by histology and nodal status (p < 0.0001): epithelioid, node negative (solid line); epithelioid, node positive (dotted line); nonepithelioid, node negative (dashed line); and nonepithelioid, node positive (dot-dashed line). (Epi = epithelioid; neg = negative; non-epi = nonepithelioid; pos = positive.) The Annals of Thoracic Surgery 2007 84, 1685-1693DOI: (10.1016/j.athoracsur.2007.04.076) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival of patients who had extrapleural pneumonectomy with intensity-modulated radiation therapy (n = 63). The Annals of Thoracic Surgery 2007 84, 1685-1693DOI: (10.1016/j.athoracsur.2007.04.076) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Survival of patients who had extrapleural pneumonectomy with intensity-modulated radiation therapy (n = 63) by pathologic stage (p = not significant): stage I (dashed line); stage II (dotted line); stage III (solid line); and stage IV (dot-dashed line). The Annals of Thoracic Surgery 2007 84, 1685-1693DOI: (10.1016/j.athoracsur.2007.04.076) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions